Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty.
Omar M SaidMohamed G A SalehAhmed F OmarAhmed A AbdouAli Natag Riad MostafaPublished in: Clinical ophthalmology (Auckland, N.Z.) (2020)
Topical difluprednate is potentially effective and safe in preventing graft rejection after penetrating keratoplasty. Larger prospective clinical trials are warranted.